封面
市場調查報告書
商品編碼
1679320

分子農業市場至2030年的預測:按類型、規模、作物來源、技術、應用、最終用戶和地區的全球分析

Molecular Farming Market Forecasts to 2030 - Global Analysis By Type (Plant-Based, Animal-Based, and Other Types), Scale, Crop Source, Technology, Application, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料,2024年全球分子農業市場價值為 5.3175億美元,預計到2030年將達到 13.7103億美元,預測期內的年複合成長率為 17.1%。

分子農業是利用基因改造植物、微生物和藻類生產有用的生物產品(包括蛋白質、疫苗、酵素和生質燃料)的過程。特定基因可引進生物體,使其能夠合成所需的化學物質,提供一種可擴展且廉價的傳統生產技術替代方案。分子農業在製藥、農業和工業領域的應用日益廣泛。它加速了生物技術的進步,並有助於為能源、食品生產和醫學提供永續的解決方案。

生物製藥需求不斷成長

隨著糖尿病、癌症和心血管疾病等慢性疾病的發生率上升,對生物製藥的需求也日益成長。生物製藥提供有針對性的有效治療方法,推動分子農業市場的成長。此外,生物技術和基因工程的進步使得利用植物系統生產複雜的蛋白質和抗體成為可能。這些系統通常比傳統方法更具成本效益和擴充性。不斷成長的生物製藥市場為分子農業技術的發展創造了良好的環境。

初期投資高

分子農業企業需要在基礎設施、機械和技術方面進行大量的初始投資。高昂的初始成本對於新參與企業和小型企業來說可能是一個巨大的障礙。此外,透過分子農業生產的生物製藥的監管核准過程可能很長且昂貴。公司還必須投資研發來最佳化生產流程並確保產品品質。這些經濟挑戰可能會阻礙分子農業市場的成長和擴張。

對植物性蛋白質的需求不斷增加

出於健康、環境和道德的考慮,消費者的偏好轉向植物來源飲食。這一趨勢導致對植物蛋白的需求日益成長,植物蛋白被視為動物產品的永續且更健康的替代品。分子農業透過生產高品質的植物蛋白為滿足這一需求提供了一個有希望的解決方案。此外,基因工程的進步使得生產具有特定營養和功能特性的客製化蛋白質成為可能。植物性飲食的日益普及為分子農業市場創造了巨大的成長機會。

易受環境因素影響

易受害蟲、疾病和氣候變遷等環境因素影響的農業系統是分子農業管理的基礎。這些因素會影響作物產量、產品品質和整體生產力。例如,乾旱和洪水等極端天氣事件會毀壞作物並擾亂生產。此外,害蟲和疾病能夠迅速蔓延並對植物造成嚴重損害。降低這些風險需要強力的農業實踐、對有彈性的作物品種的投資以及有效的害蟲管理策略。

COVID-19 的影響

COVID-19 疫情對分子農業市場產生了重大影響。這場疫情凸顯了生物製藥的重要性,並加速了新治療方法和疫苗的開發。分子農業作為快速高效生產生物製藥的潛在平台而備受關注。此外,疫情加速了對生物技術和醫療保健基礎設施的投資,為分子農業技術創造了機會。然而,疫情期間供應鏈中斷和物流挑戰也為市場帶來了障礙。

預計在預測期內,植物來源市場將成為最大的市場。

由於消費者對永續和健康食品的偏好增加,預計植物來源食品將在預測期內佔據最大的市場佔有率。透過分子農業生產的植物性蛋白質為傳統動物性蛋白質提供了可行替代品。此外,植物蛋白的環境效益,如減少溫室氣體排放和減少資源使用,進一步推動了它的普及。人們對健康和環境問題的認知不斷提高,推動了分子農業市場中植物來源產品的擴張。

預計預測期內製藥業將實現最高的年複合成長率。

由於對創新且具有成本效益的藥物、疫苗和透過分子農業生產的治療性蛋白質的需求不斷成長,預計製藥業將在預測期內實現最高成長率。此外,分子農業可以快速生產治療性蛋白質,以應對新出現的健康威脅。製藥業致力於開發各種疾病(包括感染疾病和慢性病)的新治療方法,推動了對分子農業技術的需求。

佔比最大的地區:

預計預測期內亞太地區將佔據最大的市場佔有率。該地區龐大的人口和不斷成長的醫療支出推動對先進生物製藥的需求。此外,政府支持醫療保健和醫學研究的措施也促進了市場的成長。強勁的生物技術產業和持續的研發投入進一步加強了亞太地區的分子農業市場。隨著該地區的不斷發展,對生物製藥的需求預計將增加,使其成為分子農業技術的重要市場。

年複合成長率最高的地區:

預計北美地區在預測期內將呈現最高的年複合成長率。這是由於醫療保健基礎設施不斷發展以及老齡人口不斷增加。該地區肌萎縮性脊髓側索硬化症(ALS)和老年失智症症等神經退化性疾病的發生率日益增加,對 NfL 等準確、靈敏的生物標記的需求也隨之增加。此外,北美擁有著名的製藥和生物技術公司,促進了基於 NfL 的診斷測試和治療性介入的開發和行銷。

免費客製化服務

訂閱此報告的客戶可以選擇以下免費自訂選項之1:

  • 公司簡介
    • 對其他市場公司(最多3家公司)進行全面分析
    • 主要企業的SWOT 分析(最多3家公司)
  • 地理細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和年複合成長率(註:基於可行性檢查)
  • 競爭性基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二手研究資料資訊來源
    • 先決條件

第3章 市場走勢分析

  • 促進因素
  • 限制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭敵對

第5章 全球分子農業市場(依類型)

  • 植物來源
  • 動物來源
  • 其他類型

第6章 全球分子農業市場(依規模)

  • 先導性規模生產
  • 實驗室規模生產
  • 商業規模生產

第7章 全球分子農業市場(依作物來源)

  • 玉米
  • 大麥
  • 菸草
  • 紅花
  • 紫花苜蓿
  • 其他作物來源

第8章 全球分子農業市場(依技術)

  • RNA干擾(RNAi)
  • 農桿菌介導的基因轉移
  • 基因改造植物
  • 農桿菌浸潤法
  • 電穿孔
  • 其他技術

第9章 全球分子農業市場(依應用)

  • 食品和飼料
  • 工業酵素
  • 營養補充品
  • 乳製品
  • 其他用途

第10章 全球分子農業市場(依最終用戶)

  • 農業產業
  • 生技及製藥公司
  • 研究和學術機構
  • 契約製造組織(CMO)
  • 其他最終用戶

第11章 全球分子農業市場(依地區)

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第13章 公司概況

  • Syngenta AG
  • Monsanto
  • Corteva Agriscience
  • Medicago Inc.
  • SAB Biotherapeutics
  • Zymergen
  • Mapp Biopharmaceuticals
  • Ventria Bioscience
  • ArcelorMittal
  • GreenGate Biotech
  • Evonik Industries
  • NexBio
  • BASF SE
  • Tobacco Biotechnology Company(TBC)
  • Kirin Holdings Company, Ltd.
Product Code: SMRC28903

According to Stratistics MRC, the Global Molecular Farming Market is accounted for $531.75 million in 2024 and is expected to reach $1371.03 million by 2030 growing at a CAGR of 17.1% during the forecast period. Molecular farming is the process of producing useful bioproducts including proteins, vaccines, enzymes, and biofuels by using genetically engineered plants, microbes, or algae. It offers a scalable and affordable substitute for conventional production techniques by introducing particular genes into organisms to allow them to synthesis desired chemicals. Molecular farming is being used more and more in the pharmaceutical, agricultural, and industrial sectors. It is promoting biotechnology advancements and helping to provide sustainable solutions for energy, food production, and medicine.

Market Dynamics:

Driver:

Growing demand for biopharmaceuticals

The need for biopharmaceuticals is growing along with the prevalence of chronic diseases like diabetes, cancer, and cardiovascular disorders. Biopharmaceuticals offer targeted and effective treatments, driving growth in the molecular farming market. Additionally, advancements in biotechnology and genetic engineering have made it possible to produce complex proteins and antibodies using plant-based systems. These systems are often more cost-effective and scalable compared to traditional methods. The growing biopharmaceutical market creates a favourable environment for molecular farming technologies to thrive.

Restraint:

High initial investment

Molecular farming enterprises involve a large initial investment in infrastructure, machinery, and technology. This high initial cost can be a significant barrier for new entrants and smaller companies. Additionally, the regulatory approval process for biopharmaceuticals produced through molecular farming can be lengthy and expensive. Companies must also invest in research and development to optimize production processes and ensure product quality. These financial challenges can hinder the growth and expansion of the molecular farming market.

Opportunity:

Rising demand for plant-based proteins

Consumer preferences are shifting towards plant-based diets, driven by health, environmental, and ethical considerations. This trend has led to a growing demand for plant-based proteins, which are seen as sustainable and healthy alternatives to animal-based products. Molecular farming offers a promising solution to meet this demand by producing high-quality plant-based proteins. Additionally, advancements in genetic engineering enable the production of customized proteins with specific nutritional and functional properties. The increasing popularity of plant-based diets presents a significant growth opportunity for the molecular farming market.

Threat:

Vulnerability to environmental factors

Agricultural systems that are susceptible to environmental factors including pests, diseases, and climate change are the basis of molecular farming operations. These factors can impact crop yields, product quality, and overall productivity. For example, extreme weather events such as droughts or floods can devastate crops and disrupt production. Additionally, pests and diseases can spread rapidly and cause significant damage to plants. Mitigating these risks requires robust agricultural practices, investment in resilient crop varieties, and effective pest and disease management strategies.

Covid-19 Impact

The COVID-19 pandemic has had a profound impact on the molecular farming market. The pandemic has highlighted the importance of biopharmaceuticals and accelerated the development of new therapies and vaccines. Molecular farming has gained attention as a potential platform for producing biopharmaceuticals quickly and efficiently. Additionally, the pandemic has spurred investment in biotechnology and healthcare infrastructure, creating opportunities for molecular farming technologies. However, supply chain disruptions and logistical challenges during the pandemic have also posed obstacles for the market.

The plant-based segment is expected to be the largest during the forecast period

The plant-based segment is expected to account for the largest market share during the forecast period, due to the increasing consumer preference for sustainable and healthy food products. Plant-based proteins produced through molecular farming offer a viable alternative to traditional animal-based proteins. Additionally, the environmental benefits of plant-based proteins, such as reduced greenhouse gas emissions and lower resource usage, further drive their popularity. The growing awareness of health and environmental issues supports the expansion of the plant-based segment in the molecular farming market.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the pharmaceuticals segment is predicted to witness the highest growth rate, due to the rising need for innovative and cost-effective drugs, vaccines, and therapeutic proteins produced through molecular farming. Furthermore, molecular farming allows for the rapid production of therapeutic proteins in response to emerging health threats. The pharmaceutical industry's focus on developing new treatments for various diseases, including infectious diseases and chronic conditions, drives the demand for molecular farming technologies.

Region with largest share:

During the forecast period, Asia Pacific region is expected to hold the largest market share, due to the region's large population and increasing healthcare expenditure drive the demand for advanced biopharmaceuticals. Additionally, government initiatives to support healthcare and medical research contribute to the market's growth. The presence of a robust biotechnology industry and ongoing investments in R&D further bolster the molecular farming market in the Asia Pacific region. As the region continues to develop, the demand for biopharmaceuticals is expected to increase, making it a crucial market for molecular farming technologies.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to a developed healthcare infrastructure, a growing senior population. The increasing incidence of neurodegenerative illnesses like ALS and Alzheimer's in the area has raised the need for precise and sensitive biomarkers like NfL. Furthermore, the development and marketing of NfL-based diagnostic tests and therapeutic interventions have been expedited by the presence of prominent pharmaceutical and biotechnology firms in North America.

Key players in the market

Some of the key players profiled in the Molecular Farming Market include Syngenta AG, Monsanto, Corteva Agriscience, Medicago Inc., SAB Biotherapeutics, Zymergen, Mapp Biopharmaceuticals, Ventria Bioscience, ArcelorMittal, GreenGate Biotech, Evonik Industries, NexBio, BASF SE, Tobacco Biotechnology Company (TBC), and Kirin Holdings Company, Ltd.

Key Developments:

In November 2024, McDonald's USA, syngenta and lopez foods collaborate to help produce beef more sustainably in the US, Syngenta, McDonald's and Lopez Foods announce collaboration aimed at helping to reduce certain environmental impacts during beef production.

In November 2024, Corteva Inc. announced a collaboration with bp on the companies' shared intent to form a crop-based biofuel feedstock joint venture (JV). The JV envisaged by Corteva and bp would produce and deliver crop-based biofuel feedstocks to help meet the anticipated growth in demand for 'sustainable aviation fuel' (SAF).

Types Covered:

  • Plant-Based
  • Animal-Based
  • Other Types

Scales Covered:

  • Pilot-Scale Production
  • Lab-Scale Production
  • Commercial-Scale Production

Crop Sources Covered:

  • Maize
  • Barley
  • Tobacco
  • Safflower
  • Rice
  • Alfalfa
  • Other Crop Sources

Technologies Covered:

  • RNA Interference (RNAi)
  • Agrobacterium-Mediated Gene Transfer
  • Transgenic Plants
  • Agroinfiltration
  • Electroporation
  • Other Technologies

Applications Covered:

  • Food & Feed
  • Industrial Enzymes
  • Nutraceuticals
  • Dairy
  • Other Applications

End Users Covered:

  • Agricultural Industry
  • Biotechnology & Pharmaceutical Companies
  • Research Institutions & Academia
  • Contract Manufacturing Organizations (CMOs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Molecular Farming Market, By Type

  • 5.1 Introduction
  • 5.2 Plant-Based
  • 5.3 Animal-Based
  • 5.4 Other Types

6 Global Molecular Farming Market, By Scale

  • 6.1 Introduction
  • 6.2 Pilot-Scale Production
  • 6.3 Lab-Scale Production
  • 6.4 Commercial-Scale Production

7 Global Molecular Farming Market, By Crop Source

  • 7.1 Introduction
  • 7.2 Maize
  • 7.3 Barley
  • 7.4 Tobacco
  • 7.5 Safflower
  • 7.6 Rice
  • 7.7 Alfalfa
  • 7.8 Other Crop Sources

8 Global Molecular Farming Market, By Technology

  • 8.1 Introduction
  • 8.2 RNA Interference (RNAi)
  • 8.3 Agrobacterium-Mediated Gene Transfer
  • 8.4 Transgenic Plants
  • 8.5 Agroinfiltration
  • 8.6 Electroporation
  • 8.7 Other Technologies

9 Global Molecular Farming Market, By Application

  • 9.1 Introduction
  • 9.2 Food & Feed
  • 9.3 Industrial Enzymes
  • 9.4 Nutraceuticals
  • 9.5 Dairy
  • 9.6 Other Applications

10 Global Molecular Farming Market, By End User

  • 10.1 Introduction
  • 10.2 Agricultural Industry
  • 10.3 Biotechnology & Pharmaceutical Companies
  • 10.4 Research Institutions & Academia
  • 10.5 Contract Manufacturing Organizations (CMOs)
  • 10.6 Other End Users

11 Global Molecular Farming Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Syngenta AG
  • 13.2 Monsanto
  • 13.3 Corteva Agriscience
  • 13.4 Medicago Inc.
  • 13.5 SAB Biotherapeutics
  • 13.6 Zymergen
  • 13.7 Mapp Biopharmaceuticals
  • 13.8 Ventria Bioscience
  • 13.9 ArcelorMittal
  • 13.10 GreenGate Biotech
  • 13.11 Evonik Industries
  • 13.12 NexBio
  • 13.13 BASF SE
  • 13.14 Tobacco Biotechnology Company (TBC)
  • 13.15 Kirin Holdings Company, Ltd.

List of Tables

  • Table 1 Global Molecular Farming Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Molecular Farming Market Outlook, By Type (2022-2030) ($MN)
  • Table 3 Global Molecular Farming Market Outlook, By Plant-Based (2022-2030) ($MN)
  • Table 4 Global Molecular Farming Market Outlook, By Animal-Based (2022-2030) ($MN)
  • Table 5 Global Molecular Farming Market Outlook, By Other Types (2022-2030) ($MN)
  • Table 6 Global Molecular Farming Market Outlook, By Scale (2022-2030) ($MN)
  • Table 7 Global Molecular Farming Market Outlook, By Pilot-Scale Production (2022-2030) ($MN)
  • Table 8 Global Molecular Farming Market Outlook, By Lab-Scale Production (2022-2030) ($MN)
  • Table 9 Global Molecular Farming Market Outlook, By Commercial-Scale Production (2022-2030) ($MN)
  • Table 10 Global Molecular Farming Market Outlook, By Crop Source (2022-2030) ($MN)
  • Table 11 Global Molecular Farming Market Outlook, By Maize (2022-2030) ($MN)
  • Table 12 Global Molecular Farming Market Outlook, By Barley (2022-2030) ($MN)
  • Table 13 Global Molecular Farming Market Outlook, By Tobacco (2022-2030) ($MN)
  • Table 14 Global Molecular Farming Market Outlook, By Safflower (2022-2030) ($MN)
  • Table 15 Global Molecular Farming Market Outlook, By Rice (2022-2030) ($MN)
  • Table 16 Global Molecular Farming Market Outlook, By Alfalfa (2022-2030) ($MN)
  • Table 17 Global Molecular Farming Market Outlook, By Other Crop Sources (2022-2030) ($MN)
  • Table 18 Global Molecular Farming Market Outlook, By Technology (2022-2030) ($MN)
  • Table 19 Global Molecular Farming Market Outlook, By RNA Interference (RNAi) (2022-2030) ($MN)
  • Table 20 Global Molecular Farming Market Outlook, By Agrobacterium-Mediated Gene Transfer (2022-2030) ($MN)
  • Table 21 Global Molecular Farming Market Outlook, By Transgenic Plants (2022-2030) ($MN)
  • Table 22 Global Molecular Farming Market Outlook, By Agroinfiltration (2022-2030) ($MN)
  • Table 23 Global Molecular Farming Market Outlook, By Electroporation (2022-2030) ($MN)
  • Table 24 Global Molecular Farming Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 25 Global Molecular Farming Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 Global Molecular Farming Market Outlook, By Food & Feed (2022-2030) ($MN)
  • Table 27 Global Molecular Farming Market Outlook, By Industrial Enzymes (2022-2030) ($MN)
  • Table 28 Global Molecular Farming Market Outlook, By Nutraceuticals (2022-2030) ($MN)
  • Table 29 Global Molecular Farming Market Outlook, By Dairy (2022-2030) ($MN)
  • Table 30 Global Molecular Farming Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 31 Global Molecular Farming Market Outlook, By End User (2022-2030) ($MN)
  • Table 32 Global Molecular Farming Market Outlook, By Agricultural Industry (2022-2030) ($MN)
  • Table 33 Global Molecular Farming Market Outlook, By Biotechnology & Pharmaceutical Companies (2022-2030) ($MN)
  • Table 34 Global Molecular Farming Market Outlook, By Research Institutions & Academia (2022-2030) ($MN)
  • Table 35 Global Molecular Farming Market Outlook, By Contract Manufacturing Organizations (CMOs) (2022-2030) ($MN)
  • Table 36 Global Molecular Farming Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.